Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer

Christine G. Gourin, Tammara Watts, Hadyn T. Williams, Vijay S. Patel, Paul A. Bilodeau, Teresa A. Coleman

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objectives: To investigate the utility of positron-emission tomography/computed tomography (PET-CT) in identifying distant metastatic disease in patients with suspected recurrent head and neck squamous cell cancer (HNSCC). Study Design: Retrospective analysis. Methods: Retrospective analysis of 64 consecutive patients with suspected recurrent HNSCC following definitive treatment who underwent PET-CT imaging were eligible for inclusion. Patients with previous known distant metastatic disease were excluded. Results: The majority of patients (81%) had TNM stage III or IV disease. PET-CT was suspicious for pulmonary malignancy in 14 patients (22%) and indeterminate in 6 patients (9%). Pulmonary metastases or a new lung primary were present in 10 patients (16%): 7 of 14 patients with positive PET-CT scans (50%) and 3 of 50 patients with negative or indeterminate PET-CT scans (6%). Including nonpulmonary sites, the overall incidence of distant disease was 23% (15/64) with 20% (13/64) unsuspected prior to PET-CT. The sensitivity and specificity of PET-CT in predicting distant malignancy was 86% and 84%, respectively, with a positive predictive value of 60% and a negative predictive value of 95%. There was a significant correlation between standardized uptake value (SUV) on PET-CT and positive histology, with a mean SUV of 8.5 (range, 4.7-16.2) in patients with distant metastases compared with a mean SUV of 2.9 (range, 1.9-4.2) in patients with benign pathology (r=0.87, P<.0001).

Original languageEnglish (US)
Pages (from-to)703-706
Number of pages4
JournalLaryngoscope
Volume119
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Neoplasm Metastasis
Squamous Cell Neoplasms
Lung
Positron Emission Tomography Computed Tomography
Head
Neoplasms
Histology
Retrospective Studies
Pathology
Sensitivity and Specificity

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Medicine(all)

Cite this

Gourin, C. G., Watts, T., Williams, H. T., Patel, V. S., Bilodeau, P. A., & Coleman, T. A. (2009). Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. Laryngoscope, 119(4), 703-706. https://doi.org/10.1002/lary.20118

Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. / Gourin, Christine G.; Watts, Tammara; Williams, Hadyn T.; Patel, Vijay S.; Bilodeau, Paul A.; Coleman, Teresa A.

In: Laryngoscope, Vol. 119, No. 4, 04.2009, p. 703-706.

Research output: Contribution to journalArticle

Gourin, CG, Watts, T, Williams, HT, Patel, VS, Bilodeau, PA & Coleman, TA 2009, 'Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer', Laryngoscope, vol. 119, no. 4, pp. 703-706. https://doi.org/10.1002/lary.20118
Gourin, Christine G. ; Watts, Tammara ; Williams, Hadyn T. ; Patel, Vijay S. ; Bilodeau, Paul A. ; Coleman, Teresa A. / Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. In: Laryngoscope. 2009 ; Vol. 119, No. 4. pp. 703-706.
@article{2b1d1332b33d4880b70db3550a695d52,
title = "Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer",
abstract = "Objectives: To investigate the utility of positron-emission tomography/computed tomography (PET-CT) in identifying distant metastatic disease in patients with suspected recurrent head and neck squamous cell cancer (HNSCC). Study Design: Retrospective analysis. Methods: Retrospective analysis of 64 consecutive patients with suspected recurrent HNSCC following definitive treatment who underwent PET-CT imaging were eligible for inclusion. Patients with previous known distant metastatic disease were excluded. Results: The majority of patients (81{\%}) had TNM stage III or IV disease. PET-CT was suspicious for pulmonary malignancy in 14 patients (22{\%}) and indeterminate in 6 patients (9{\%}). Pulmonary metastases or a new lung primary were present in 10 patients (16{\%}): 7 of 14 patients with positive PET-CT scans (50{\%}) and 3 of 50 patients with negative or indeterminate PET-CT scans (6{\%}). Including nonpulmonary sites, the overall incidence of distant disease was 23{\%} (15/64) with 20{\%} (13/64) unsuspected prior to PET-CT. The sensitivity and specificity of PET-CT in predicting distant malignancy was 86{\%} and 84{\%}, respectively, with a positive predictive value of 60{\%} and a negative predictive value of 95{\%}. There was a significant correlation between standardized uptake value (SUV) on PET-CT and positive histology, with a mean SUV of 8.5 (range, 4.7-16.2) in patients with distant metastases compared with a mean SUV of 2.9 (range, 1.9-4.2) in patients with benign pathology (r=0.87, P<.0001).",
author = "Gourin, {Christine G.} and Tammara Watts and Williams, {Hadyn T.} and Patel, {Vijay S.} and Bilodeau, {Paul A.} and Coleman, {Teresa A.}",
year = "2009",
month = "4",
doi = "10.1002/lary.20118",
language = "English (US)",
volume = "119",
pages = "703--706",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer

AU - Gourin, Christine G.

AU - Watts, Tammara

AU - Williams, Hadyn T.

AU - Patel, Vijay S.

AU - Bilodeau, Paul A.

AU - Coleman, Teresa A.

PY - 2009/4

Y1 - 2009/4

N2 - Objectives: To investigate the utility of positron-emission tomography/computed tomography (PET-CT) in identifying distant metastatic disease in patients with suspected recurrent head and neck squamous cell cancer (HNSCC). Study Design: Retrospective analysis. Methods: Retrospective analysis of 64 consecutive patients with suspected recurrent HNSCC following definitive treatment who underwent PET-CT imaging were eligible for inclusion. Patients with previous known distant metastatic disease were excluded. Results: The majority of patients (81%) had TNM stage III or IV disease. PET-CT was suspicious for pulmonary malignancy in 14 patients (22%) and indeterminate in 6 patients (9%). Pulmonary metastases or a new lung primary were present in 10 patients (16%): 7 of 14 patients with positive PET-CT scans (50%) and 3 of 50 patients with negative or indeterminate PET-CT scans (6%). Including nonpulmonary sites, the overall incidence of distant disease was 23% (15/64) with 20% (13/64) unsuspected prior to PET-CT. The sensitivity and specificity of PET-CT in predicting distant malignancy was 86% and 84%, respectively, with a positive predictive value of 60% and a negative predictive value of 95%. There was a significant correlation between standardized uptake value (SUV) on PET-CT and positive histology, with a mean SUV of 8.5 (range, 4.7-16.2) in patients with distant metastases compared with a mean SUV of 2.9 (range, 1.9-4.2) in patients with benign pathology (r=0.87, P<.0001).

AB - Objectives: To investigate the utility of positron-emission tomography/computed tomography (PET-CT) in identifying distant metastatic disease in patients with suspected recurrent head and neck squamous cell cancer (HNSCC). Study Design: Retrospective analysis. Methods: Retrospective analysis of 64 consecutive patients with suspected recurrent HNSCC following definitive treatment who underwent PET-CT imaging were eligible for inclusion. Patients with previous known distant metastatic disease were excluded. Results: The majority of patients (81%) had TNM stage III or IV disease. PET-CT was suspicious for pulmonary malignancy in 14 patients (22%) and indeterminate in 6 patients (9%). Pulmonary metastases or a new lung primary were present in 10 patients (16%): 7 of 14 patients with positive PET-CT scans (50%) and 3 of 50 patients with negative or indeterminate PET-CT scans (6%). Including nonpulmonary sites, the overall incidence of distant disease was 23% (15/64) with 20% (13/64) unsuspected prior to PET-CT. The sensitivity and specificity of PET-CT in predicting distant malignancy was 86% and 84%, respectively, with a positive predictive value of 60% and a negative predictive value of 95%. There was a significant correlation between standardized uptake value (SUV) on PET-CT and positive histology, with a mean SUV of 8.5 (range, 4.7-16.2) in patients with distant metastases compared with a mean SUV of 2.9 (range, 1.9-4.2) in patients with benign pathology (r=0.87, P<.0001).

UR - http://www.scopus.com/inward/record.url?scp=65249141047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249141047&partnerID=8YFLogxK

U2 - 10.1002/lary.20118

DO - 10.1002/lary.20118

M3 - Article

C2 - 19205017

AN - SCOPUS:65249141047

VL - 119

SP - 703

EP - 706

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 4

ER -